2010
Characterizing Declines in Pediatric Antidepressant Use After New Risk Disclosures
Busch SH, Frank RG, Martin A, Barry CL. Characterizing Declines in Pediatric Antidepressant Use After New Risk Disclosures. Medical Care Research And Review 2010, 68: 96-111. PMID: 20675349, PMCID: PMC2974787, DOI: 10.1177/1077558710374197.Peer-Reviewed Original ResearchConceptsAntidepressant usePediatric antidepressant useAntidepressant medication useNew treatment episodeNew safety informationRisk of suicidalityAntidepressant medicationMedication useTreatment patternsTreatment episodesHealth outcomesLatter groupChildrenSafety informationFamily characteristicsCollege-educated parentsExperienced declinesMedicationsAntidepressantsDeclineFindingsSuicidalityAntidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
Busch SH, Frank RG, Leslie DL, Martin A, Rosenheck RA, Martin EG, Barry CL. Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns? Psychiatric Services 2010, 61: 11-6. PMID: 20044412, PMCID: PMC2801076, DOI: 10.1176/appi.ps.61.1.11.Peer-Reviewed Original ResearchConceptsMajor depressive disorderAntidepressant useTreatment patternsDepressive disorderFDA safety warningsSpecific safety informationThomson Reuters MarketScanUse of paroxetineRisk of suicidalitySafety warningsAntidepressant treatmentOutpatient visitsTreatment episodesTreatment recommendationsPractice patternsNew episodesDrug AdministrationSuicide riskFDA recommendationsDepressed childrenU.S. FoodFDAAntidepressantsChildrenEvidence of increases
2006
Foreword Blues' Clues
Martin A. Foreword Blues' Clues. Child And Adolescent Psychiatric Clinics Of North America 2006, 15: xiii-xv. PMID: 16952761, DOI: 10.1016/j.chc.2006.07.002.Peer-Reviewed Original Research
2005
Antidepressant‐Induced Manic Conversion: A Developmentally Informed Synthesis of the Literature
Lim CJ, Leckman JF, Young C, Martin A. Antidepressant‐Induced Manic Conversion: A Developmentally Informed Synthesis of the Literature. International Review Of Neurobiology 2005, 65: 25-52. PMID: 16140052, DOI: 10.1016/s0074-7742(04)65002-1.Peer-Reviewed Original ResearchConceptsAddition of antidepressantsResolution of symptomsAntidepressant-induced maniaSerotonin reuptake inhibitorsMood stabilizer therapyLess nursing careMost case reportsRapid cyclingManic conversionSpontaneous maniaAntidepressant medicationReuptake inhibitorsAntidepressant exposureBipolar depressionCase reportManic episodesMood destabilizationSpontaneous episodesDistressing conditionSevere depressionClinical recommendationsManic symptomsNursing careSelective SSRIPatient screening
2004
Age Effects on Antidepressant-Induced Manic Conversion
Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D. Age Effects on Antidepressant-Induced Manic Conversion. JAMA Pediatrics 2004, 158: 773-780. PMID: 15289250, DOI: 10.1001/archpedi.158.8.773.Peer-Reviewed Original ResearchConceptsManic conversionAntidepressant classesPatient ageTime-dependent Cox proportional hazards modelsSelective serotonin reuptake inhibitorsCox proportional hazards modelNonbipolar mood disorderSerotonin reuptake inhibitorsProportional hazards modelRisk of conversionAdministrative national databaseEffect of agePharmacy claimsReuptake inhibitorsAntidepressant exposureDrug therapyTricyclic antidepressantsPeripubertal childrenAge effectsBipolar illnessMood disordersHigh riskMental health usersAntidepressant categoryHazards model
2000
Pharmacotherapy of Early-Onset Depression Update and New Directions
Martin A, Kaufman J, Charney D. Pharmacotherapy of Early-Onset Depression Update and New Directions. Child And Adolescent Psychiatric Clinics Of North America 2000, 9: 135-157. PMID: 10674194, DOI: 10.1016/s1056-4993(18)30139-1.Peer-Reviewed Original ResearchConceptsEarly-onset depressionDepressive disorderSafety dataLong-term exposureBrain-derived neurotrophic factor levelsLong-term safety dataEarly-onset depressive disordersAvailable antidepressant agentsRigid treatment guidelinesUseful treatment interventionsNeurotrophic factor levelsLong-term followShort-term efficacyShort-term efficacy dataAtrophic brain changesHigh recurrence ratePsychopharmacology Algorithm ProjectRoutine clinical practiceAlternative treatment strategiesYears of ageShort-term trialsPaucity of dataRisk-benefit analysisLong-term useAntidepressant medication